Navigation Links
Pollogen Announces Appointment of Ms. Yfat Scialom as Chief Executive Officer
Date:8/5/2008

TEL AVIV, Israel, BADAJOZ, Spain and SINGAPORE, August 5 /PRNewswire/ -- Pollogen Ltd. announced that Ms. Yfat Scialom has been appointed as the new Chief Executive Officer effective July 20, 2008.

Ms. Scialom comes to Pollogen with 20 years of experience in sales, marketing and senior management in the medical and aesthetic field. She previously served as VP of Marketing and Sales at UltraShape Ltd., a leader in non-invasive body contouring solutions. Ms. Scialom established the marketing and sales infrastructure and was responsible for the successful launch of the Company's products, defining the branding, positioning, and the formation of a global distribution network in 50 countries and 3 direct subsidiaries, driving sales from zero to tens of millions of dollars.

Ms. Scialom formerly served as a Senior Marketing Director of Oridion BreathID, a manufacturer of medical equipment in the field of Gastroenterology. Prior to Oridion, she acted as the General Manager of Sunlight Medical Europe, a medical device company in the field of ultrasound. Ms. Scialom holds a B.Sc. in Economics and Management from the Hebrew University of Jerusalem and an MBA from the Ben-Gurion University.

While Ms. Scialom will be the new CEO, Dr. Zion Azar and Mr. Pini Shalev will maintain an active role in their current positions as Chairman and CTO.

"As Pollogen and its sales of TriPollar(TM) based systems continue to grow, we feel that Ms. Scialom is the right CEO for the Company. We were impressed by Ms. Scialom's proven track record and believe that she will bring leadership and ingenuity as well as continue to build the Company and expand its sales and infrastructure," stated Dr. Zion Azar, Pollogen's Chairman. "We believe that Ms. Scialom will play a key role in maintaining TriPollar as the industry gold standard. We look forward to have Ms. Scialom as part of our Pollogen's management team and to her contribution to the continued growth and developm
'/>"/>

SOURCE Pollogen Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Molecular Biometrics Announces Results of Parkinsons Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology
2. SemBioSys announces second quarter 2008 financial and operational results
3. Reminder: Webcast Alert: Transgenomic Inc. Announces Second Quarter 2008 Earnings Release Conference Call Webcast
4. Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast
5. Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
6. NanoLogix Inc. Announces Joint Development With CL Solutions and First Sales of Rapid Detection Kits
7. CryoLife Announces Management Promotions
8. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
9. Cantel Medical Announces Management Succession at Crosstex Healthcare Disposables Subsidiary
10. Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
11. Novavax Announces Closing of $18 Million Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... Calif. , June 29, 2015   Veracyte, ... company pioneering the field of molecular cytology, today announced ... News Group,s prestigious Top Workplaces list for the second ... Workplace winners based solely on an annual survey of ... and honored that the degree to which Veracyte values ...
(Date:6/29/2015)... -- Elsevier , a world-leading provider ... today announced the highlights of its journal Impact Factor ... Reports® (JCR) published by Thomson Reuters, Elsevier saw 55% ... 2014, ahead of the aggregate across other journals. In ... subject categories, up from 61 in 2013. ...
(Date:6/26/2015)... June 26, 2015   Aratana Therapeutics, ... pet therapeutics company focused on the licensing, ... for companion animals, today announced positive results ... capromorelin (AT-002), the company,s innovative therapeutic for ... small molecule that mimics ghrelin, the naturally ...
(Date:6/26/2015)... MA (PRWEB) , ... June 26, 2015 , ... ... U.S. Department of Agriculture (USDA), Grain Inspection, Packers and Stockyards Administration (GIPSA) awarded ... to as vomitoxin in feed and grains utilizing Charm’s ROSA DONQ-FAST5 Test. This ...
Breaking Biology Technology:Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 2Veracyte Named a 2015 "Top Workplace" in the San Francisco Bay Area 3Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 2Aratana Therapeutics Announces Positive Pivotal Results for AT-002 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 5USDA-GIPSA (FGIS) Awards 5 Year Contract for Vomitoxin Tests to Charm Sciences 2
... Sigma Life Science, the innovative biological ... SIAL ), today announced that its SAGE Labs initiative ... (ZFN) technology to generate knock-in rats in which foreign ... genome in a precisely targeted manner.  This breakthrough achievement ...
... QuantaLife, Inc. announced today that it ... of the proceeds will be used to establish commercial ... Digital™ PCR platform, into the life sciences research market ... tests. Paladin Capital Group, together with other existing investors ...
... YORK, Dec. 10, 2010 Ramius V&O Acquisition LLC, ... that it has sent a letter to the Board ... CYPB ) outlining its willingness to acquire all of ... $5.50 per share.  The offer is conditioned upon Cypress ...
Cached Biology Technology:Sigma® Life Science Creates World's First Knock-in Rats using Zinc Finger Nuclease Technology 2Sigma® Life Science Creates World's First Knock-in Rats using Zinc Finger Nuclease Technology 3Sigma® Life Science Creates World's First Knock-in Rats using Zinc Finger Nuclease Technology 4QuantaLife, Inc. Closes $17.2M Series B Financing to Accelerate Application Development for Its Droplet Digital™ PCR Platform and Establish Commercial Operations by 2011 2Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share 2Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share 3Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share 4Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share 5Ramius Offers to Enter Into Immediate and Exclusive Negotiations to Acquire Cypress Bioscience for $5.50 Per Share 6
(Date:6/30/2015)... Genisphere announced Tom Bliss ... further develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss ... much of the last 25 years in leadership positions ... Johnson & Johnson. Tom started his career in Investment ... Finance. He graduated from Dartmouth College with a BA ...
(Date:6/25/2015)...  TAKE Solutions Ltd., a global business technology solutions ... Patent and Trademark Office (USPTO) for its "Method for ... Clinical Accelerators to reduce the time taken to standardize ... without the accelerators), thus reducing time to market. ... the heart of the patented Clinical Data Standardization Process ...
(Date:6/24/2015)... 24, 2015 Biometry authentication provider KeyLemon ... password solution one face in. ... one face in, entering the expanding biometric authentication ... multifactor-authentication biometric answer to the password problem. With ... partnership with KeyLemon, one face in allows users ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3TAKE Solutions Awarded Patent By USPTO 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... 2013 -- An important new study has revealed the ... influences gene expression profiles of breast cancer. The ... measurements may benefit from pooling of biopsies from a ... Cancer Conference in Brussels, Belgium. These findings represent ...
... Harbor, NY When a pedestrian hears the screech of a ... to move in response. Is the action taking place blocks ... truly primal mechanisms that we depend on every day of our ... sense of hearing -- is yielding its secrets to modern neuroscience. ...
... spill in the Gulf of Mexico, crude oil toxicity ... according to new findings from a research team that ... researchers from Louisiana and South Carolina, the scientists found ... locations show developmental abnormalities, including heart defects, delayed hatching ...
Cached Biology News:Study reveals magnitude of variation in gene expression measurements within breast cancers 2Study reveals magnitude of variation in gene expression measurements within breast cancers 3Scientists discover how brain's auditory center transmits information for decisions, actions 2Scientists discover how brain's auditory center transmits information for decisions, actions 3Health defects found in fish exposed to Deepwater Horizon oil spill 2
... tubes for rodent oral gavage feature soft ... perforation and trauma. Plus they are disposable, ... the risk of cross-contamination. ... 20ga Length: ...
Adult Bovine Serum US Origin...
... 13(S)-HODE-d4 contains 4 deuterium atoms at the ... intended for use as an internal standard for ... spectrometry. 13(S)-HODE is produced by incubation of linoleic ... been shown to inhibit the adhesion of tumor ...
...
Biology Products: